- Home
- VIGL vs WIMI Comparison
VIGL vs WIMI Comparison
Compare VIGL & WIMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIGL
- WIMI
- Stock Information
- Founded
- VIGL 2020
- WIMI 2015
- Country
- VIGL United States
- WIMI China
- Employees
- VIGL N/A
- WIMI 107
- Industry
- VIGL Biotechnology: Pharmaceutical Preparations
- WIMI Computer Software: Prepackaged Software
- Sector
- VIGL Health Care
- WIMI Technology
- Exchange
- VIGL Nasdaq
- WIMI Nasdaq
- Market Cap
- VIGL 134.9M
- WIMI 23.9M
- IPO Year
- VIGL 2022
- WIMI 2020
- Fundamental
- Price
- VIGL $8.05
- WIMI $3.53
- Analyst Decision
- VIGL Buy
- WIMI
- Analyst Count
- VIGL 7
- WIMI 0
- Target Price
- VIGL $8.00
- WIMI N/A
- AVG Volume (30 Days)
- VIGL 1.1M
- WIMI 7.6M
- Earning Date
- VIGL 08-12-2025
- WIMI 01-01-0001
- Dividend Yield
- VIGL N/A
- WIMI N/A
- EPS Growth
- VIGL N/A
- WIMI N/A
- EPS
- VIGL N/A
- WIMI N/A
- Revenue
- VIGL N/A
- WIMI $84,137,968.00
- Revenue This Year
- VIGL N/A
- WIMI N/A
- Revenue Next Year
- VIGL N/A
- WIMI N/A
- P/E Ratio
- VIGL N/A
- WIMI N/A
- Revenue Growth
- VIGL N/A
- WIMI 19.25
- 52 Week Low
- VIGL $1.31
- WIMI $0.27
- 52 Week High
- VIGL $8.06
- WIMI $2.92
- Technical
- Relative Strength Index (RSI)
- VIGL 88.18
- WIMI 60.88
- Support Level
- VIGL $7.86
- WIMI $2.73
- Resistance Level
- VIGL $8.05
- WIMI $3.09
- Average True Range (ATR)
- VIGL 0.02
- WIMI 0.26
- MACD
- VIGL -0.15
- WIMI 0.15
- Stochastic Oscillator
- VIGL 73.15
- WIMI 83.58
About VIGL Vigil Neuroscience Inc.
Vigil Neuroscience Inc is a clinical-stage biotechnology company engaged in improving the lives of patients, caregivers, and families affected by rare and common neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. Microglia are the sentinel immune cells of the brain and play a critical role in maintaining central nervous system (CNS) health and responding to damage caused by disease. The group provides solutions for fully human monoclonal antibody and Oral small molecule TERM2 agonist.
About WIMI WiMi Hologram Cloud Inc.
WiMi Hologram Cloud Inc and its subsidiaries offer augmented reality (AR) based holographic services and products to cater to its customers. Its AR service and product offerings consist of holographic AR advertising services and holographic AR entertainment products. It is also into the semiconductor business, in which the company provides central processing algorithm services and computer chip products to enterprise customers and the sales of comprehensive solutions for central processing algorithms and related services with software and hardware integration. The company reports in three segments: AR advertising, AR entertainment, and Semiconductor. Its geographical segments are Mainland China, Hong Kong, and International.